Evaluation and characterization of Fasciola hepatica tegument protein extract for serodiagnosis of human fascioliasis

Clinical and Vaccine Immunology

Volumn 19, Issue 11, 2012, Pages 1870-1878

  Morales, Adelaida ^a   Espino, Ana M ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ENOLASE; FATTY ACID BINDING PROTEIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; PARASITE ANTIBODY; PARASITE ANTIGEN; POLYPEPTIDE; TEGUMENT PROTEIN EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FASCIOLA HEPATICA; FASCIOLIASIS; HUMAN; IMMUNOREACTIVITY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; RABBIT; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SERUM; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BLOTTING, WESTERN; DIAGNOSTIC TESTS, ROUTINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASCIOLA HEPATICA; FASCIOLIASIS; HUMANS; IMMUNOGLOBULIN G; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 84868226702     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00487-12     Document Type: Article

References (59)

1. Aalberse RC, et al. 1983. IgG4 as a blocking antibody. Clin. Rev. Allergy 1:289-302.
2. Aalberse RC, van der Gaag R, van Leeuwen J. 1983. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J. Immunol. 130:722-726. (Pubitemid 13186294)
3. Abath FG, Werkhauser RC. 1996. The tegument of Schistosoma mansoni: functional and immunological features. Parasite Immunol. 18: 15-20. (Pubitemid 26059926)
4. Anuracpreeda P, Wanichanon C, Chaithirayanon K, Preyavichyapugdee N, Sobhon P. 2006. Distribution of 28.5 kDa antigen in the tegument of adult Fasciola gigantica. Acta Trop. 100:31-40. (Pubitemid 44821029)
5. Anuracpreeda P, Wanichanon C, Sobhon P. 2009. Fasciola gigantica: immunolocalization of 28.5 kDa antigen in the tegument of metacercaria and juvenile fluke. Exp. Parasitol. 122:75-83.
6. Arias M, et al. 2006. A 2.9 kDa Fasciola hepatica-recombinant protein based ELISA test for the detection of current-ovine fasciolosis trickle infected. Vet. Parasitol. 137:67-73. (Pubitemid 43384028)
7. Bernal D, et al. 2004. Identification of enolase as a plasminogen-binding protein in excretory-secretory products of Fasciola hepatica. FEBS Lett. 563:203-206. (Pubitemid 38471599)
8. Carnevale S, et al. 2001. Immunodiagnosis of fasciolosis using recombinant procathepsin L cystein proteinase. Diagn. Microbiol. Infect. Dis. 41: 43-49. (Pubitemid 33001458)
9. Carnevale S, et al. 2001. Immunodiagnosis of human fascioliasis by an enzyme-linked immunosorbent assay (ELISA) and a micro-ELISA. Clin. Diagn. Lab. Immunol. 8:174-177. (Pubitemid 32061702)
10. Chaithirayanon K, et al. 2002. Production and characterization of a monoclonal antibody against 28.5 kDa tegument antigen of Fasciola gigantica. Acta Trop. 84:1-8. (Pubitemid 35223289)
11. Cook GC, Zumla AI (ed). 2003. Fascioliasis, p 1633-1634. In Manson's Tropical Diseases. 21st ed. W. B. Saunders, Philadelphia, PA.
12. El Ridi R, et al. 2007. Fasciola gigantica excretory-secretory products for immunodiagnosis and prevention of sheep fasciolosis. Vet. Parasitol. 149: 219-228. (Pubitemid 47498750)
13. Erdman DD. 1981. Clinical comparison of ethyl acetate and diethyl ether in the formalin-ether sedimentation technique. J. Clin. Microbiol. 14: 483-485. (Pubitemid 12173190)
14. Espino AM, Dumenigo BE, Fernandez R, Finlay CM. 1987. Immunodiagnosis of human fascioliasis by enzyme-linked immunosorbent assay using excretory-secretory products. Am. J. Trop. Med. Hyg. 37: 605-608. (Pubitemid 18030052)
15. Espino AM, Hillyer GV. 2001. Identification of fatty acid molecules in a Fasciola hepatica immunoprophylactic fatty acid-binding protein. J. Parasitol. 87:426-428. (Pubitemid 32303689)
16. Fagbemi BO, Hillyer GV. 1991. Partial purification and characterisation of the proteolytic enzymes of Fasciola gigantica adult worms. Vet. Parasitol. 40:217-226.
17. Figueroa-Santiago O, Delgado B, Espino AM. 2011. Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis. Diagn. Microbiol. Infect. Dis. 70:355-361.
18. Galen RS. 1980. Predictive value and efficiency of hematology data. Blood Cells 6:185-197. (Pubitemid 10094344)
19. Galen RS. 1980. Predictive value and efficiency of laboratory testing. Pediatr. Clin. North Am. 27:861-869. (Pubitemid 11183845)
20. Garraud O, Perraut R, Riveau G, Nutman TB. 2003. Class and subclass selection in parasite-specific antibody responses. Trends Parasitol. 19: 300-304.
21. Gaudier JF, Caban-Hernandez K, Osuna A, Espino AM. 2012. Biochemical characterization and differential expression of a 16.5-kilodalton tegument- associated antigen from the liver fluke Fasciola hepatica. Clin. Vaccine Immunol. 19:325-333.
22. Hacariz O, Sayers G, Baykal AT. 2012. A proteomic approach to investigate the distribution and abundance of surface and internal Fasciola hepatica proteins during the chronic stage of natural liver fluke infection in cattle. J. Proteome Res. 11:3592-3604.
23. Hacariz O, Sayers G, Mulcahy G. 2011. A preliminary study to understand the effect of Fasciola hepatica tegument on naive macrophages and humoral responses in an ovine model. Vet. Immunol. Immunopathol. 139:245-249.
24. Hanna RE, Trudgett AG. 1983. Fasciola hepatica: development of monoclonal antibodies and their use to characterize a glycocalyx antigen in migrating flukes. Parasite Immunol. 5:409-425. (Pubitemid 13003453)
25. Hillyer GV. 1999. Immunodiagnosis of human and animal fascioliasis, p 435-447. In Dalton JP (ed). Fasciolosis. CABI Publishing, Wallingford, United Kingdom.
26. Hillyer GV. 1980. Isolation of Fasciola hepatica tegument antigens. J. Clin. Microbiol. 12:695-699. (Pubitemid 10025061)
27. Hillyer GV, Capron A. 1976. Immunodiagnosis of human fascioliasis by counterelectrophoresis. J. Parasitol. 62:1011-1013. (Pubitemid 8010869)
28. Hong ST, et al. 1999. Usefulness of IgG4 subclass antibodies for diagnosis of human clonorchiasis. Korean J. Parasitol. 37:243-248.
29. Intapan PM, Maleewong W, Sawanyawisuth K, Chotmongokol V. 2003. Evaluation of human IgG subclass antibodies in the serodiagnosis of angiostrongyliasis. Parasitol. Res. 89:425-429. (Pubitemid 36437769)
30. Iskander R, Das PK, Aalberse RC. 1981. IgG4 antibodies in Egyptian patients with schistosomiasis. Int. Arch. Allergy Appl. Immunol. 66:200-207. (Pubitemid 11003912)
31. Jefferies JR, Campbell AM, van Rossum AJ, Barrett J, Brophy PM. 2001. Proteomic analysis of Fasciola hepatica excretory-secretory products. Proteomics 1:1128-1132. (Pubitemid 33696478)
32. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
33. Lopez-Aban J, et al. 2007. Progress in the development of Fasciola hepatica vaccine using recombinant fatty acid binding protein with the adjuvant adaptation system ADAD. Vet. Parasitol. 145:287-296. (Pubitemid 46442774)
34. Lopez-Aban J, et al. 2008. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica. Vet. Parasitol. 153:176-181. (Pubitemid 351447308)
35. Loukas A, Opdebeeck J, Croese J, Prociv P. 1996. Immunoglobulin G subclass antibodies against excretory/secretory antigens of Ancylostoma caninum in human enteric infections. Am. J. Trop. Med. Hyg. 54:672-676. (Pubitemid 26244152)
36. Maher K, et al. 1999. Parasite-specific antibody profile in human fascioliasis: application for immunodiagnosis of infection. Am. J. Trop. Med. Hyg. 61:738-742.
37. Marcos L, et al. 2005. Fascioliasis in relatives of patients with Fasciola hepatica infection in Peru. Rev. Inst. Med. Trop. Sao Paulo 47:219-222. (Pubitemid 41232866)
38. Marques HH, et al. 2008. Protective effect and granuloma downmodulation promoted by RP44 antigen a fructose 1,6 bisphosphate aldolase of Schistosoma mansoni. Immunobiology 213:437-446. (Pubitemid 351619284)
39. Mas-Coma S. 2005. Epidemiology of fascioliasis in human endemic areas. J. Helminthol. 79:207-216. (Pubitemid 41192534)
40. Morphew RM, Wright HA, LaCourse EJ, Woods DJ, Brophy PM. 2007. Comparative proteomics of excretory-secretory proteins released by the liver fluke Fasciola hepatica in sheep host bile and during in vitro culture ex host. Mol. Cell. Proteomics 6:963-972. (Pubitemid 47019398)
41. Moxon JV, et al. 2010. Immune responses directed at egg proteins during experimental infection with the liver fluke Fasciola hepatica. Parasite Immunol. 32:111-124.
42. O'Neill SM, Parkinson M, Strauss W, Angles R, Dalton JP. 1998. Immunodiagnosis of Fasciola hepatica infection (fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase. Am. J. Trop. Med. Hyg. 58:417-423. (Pubitemid 28183250)
43. Paykari H, Dalimi A, Madani R. 2002. Immunization of sheep against Fasciola gigantica with glutathione S-transferase. Vet. Parasitol. 105:153-159. (Pubitemid 34252929)
44. Perez-Sanchez R, Ramajo-Hernandez A, Ramajo-Martin V, Oleaga A. 2006. Proteomic analysis of the tegument and excretory-secretory products of adult Schistosoma bovis worms. Proteomics 6(Suppl. 1):S226-S236.
45. Poopyruchpong N, Upatham VVES, Srivatanakul P. 1990. Diagnosis of opisthorchiasis by enzyme-linked immunosorbent assay using partially purified antigens. Asian Pac. J. Allergy Immunol. 8:27-31. (Pubitemid 20340486)
46. Preyavichyapugdee N, et al. 2008. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice. Exp. Parasitol. 119:229-237.
47. Robinson MW, Menon R, Donnelly SM, Dalton JP, Ranganathan S. 2009. An integrated transcriptomics and proteomics analysis of the secretome of the helminth pathogen Fasciola hepatica: proteins associated with invasion and infection of the mammalian host. Mol. Cell. Proteomics 8:1891-1907.
48. Rogers MV, Henkle KJ, Fidge NH, Mitchell GF. 1989. Identification of a multispecific lipoprotein receptor in adult Schistosoma japonicum by ligand blotting analyses. Mol. Biochem. Parasitol. 35:79-88. (Pubitemid 19137597)
49. Roldan WH, Espinoza YA. 2009. Evaluation of an enzyme-linked immunoelectrotransfer blot test for the confirmatory serodiagnosis of human toxocariasis. Mem. Inst. Oswaldo Cruz 104:411-418.
50. Sabry NM, Mohamed HM, Khattab ES, Motlaq SS, El-Agrody AM. 2011. Synthesis of 4H-chromene, coumarin, 12H-chromeno[2,3-d] pyrimidine derivatives and some of their antimicrobial and cytotoxicity activities. Eur. J. Med. Chem. 46:765-772.
51. Sexton JL, et al. 1990. Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep. J. Immunol. 145:3905-3910.
52. Sotillo J, et al. 2010. Excretory/secretory proteome of the adult stage of Echinostoma caproni. Parasitol. Res. 107:691-697.
53. Tantrawatpan C, et al. 2003. Characterisation of Fasciola gigantica adult 27-kDa excretory-secretory antigen in human fascioliasis. Parasitol. Res. 91:325-327. (Pubitemid 37363629)
54. Tantrawatpan C, et al. 2005. Serodiagnosis of human fascioliasis by a cystatin capture enzyme-linked immunosorbent assay with recombinant Fasciola gigantica cathepsin L antigen. Am. J. Trop. Med. Hyg. 72:82-86. (Pubitemid 41270312)
55. Torgerson P, Claxton J. 1999. Epidemiology and control, p 113-150. In Dalton JP (ed), Fasciolosis. CAB International, Oxford, United Kingdom.
56. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76:4350-4354. (Pubitemid 9256559)
57. WHO. 1995. Control of foodborne trematode infections. Report of a WHO Study Group. World Health Organ. Tech. Rep. Ser. 849:1-157.
58. Wilson RA, et al. 2011. Exploring the Fasciola hepatica tegument proteome. Int. J. Parasitol. 41:1347-1359.
59. Wongkham C, et al. 2005. Evaluation of immunoglobulin G subclass antibodies against recombinant Fasciola gigantica cathepsin L1 in an enzyme- linked immunosorbent assay for serodiagnosis of human fasciolosis. Clin. Diagn. Lab. Immunol. 12:1152-1156. (Pubitemid 41475822)